Q2 2024 Community Health Systems Inc Earnings Call Transcript
Key Points
- Same-store net revenues increased by 4.7% compared to the same period last year.
- Adjusted EBITDA for the quarter was $387 million, up from $373 million in the second quarter of 2023.
- Same-store admissions improved by 3%, and adjusted admissions improved by 3.2%.
- Strong outpatient volumes, including growth in emergency department visits, urgent care, and physician practices.
- Successful recruitment and retention of workforce, with nearly 3,000 registered nurses hired in the first half of 2024.
- Novant Health ended its plans to acquire Community Health Systems Inc (CYH)'s North Carolina hospitals, creating uncertainty in that market.
- Continued payer scrutiny on observation status cases, leading to significant denials and downgrades.
- Provider and other business taxes increased by $25 million compared to the prior year quarter.
- Net debt to trailing adjusted EBITDA remains high at 7.6 times, though slightly improved from previous quarters.
- Potential risks related to the expiration of enhanced subsidies for exchange business in 2026, creating uncertainty for future revenue.
Good day and welcome to the Community Health Systems second quarter 2024 earnings conference call. (Operator Instructions) Please also note today's event is being recorded.
I'd now like to turn the conference over to Mr. Anton Hie, Vice President of Investor Relations. Please go ahead.
Thank you, Rocco. Good morning and welcome to Community Health Systems second quarter 2024 conference call. Joining me on today's call are Tim Hingtgen, Chief Executive Officer, and Kevin Hammons, President and Chief Financial Officer. Before we begin I must remind everyone that this conference call may contain certain forward-looking statements, including all statements that do not relate solely to historical or current facts.
These forward-looking statements are subject to a number of known and unknown risks which are described in headings such as Risk Factors in our annual report on Form 10-K and other reports filed with or furnished to the SEC. Actual results may differ significantly from those expressed in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
